Business Standard

P&G Health declines 6% on profit booking post June quarter results

The board recommended a final dividend of Rs 230 per equity share (including a one-time special dividend of Rs 188 per equity share) for the financial year ended June 30, 2020.

The pharmaceutical company reported 11 per cent YoY decline in sales at Rs 200 crore
Premium

The pharmaceutical company reported 11 per cent YoY decline in sales at Rs 200 crore

SI Reporter Mumbai
Shares of Procter & Gamble (P&G) Health slipped 6 per cent to Rs 5,330 on the BSE in the intra-day trade on Wednesday on profit booking. The company reported 10.8 per cent year on year (YoY) growth in net profit at Rs 48.90 crore for June quarter.

The pharmaceutical company reported 11 per cent YoY decline in sales at Rs 200 crore, as the business operations got impacted across the country following the nationwide lockdown imposed to contain the spread of Covid-19.

The company's EBITDA (earnings before interest, taxes, depreciation, and amortization) margin improved to 31.7 per cent from 30.82 per cent.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in